Review: Potential druggable targets for the treatment of early onset preeclampsia

Pregnancy Hypertension

Volumn 3, Issue 4, 2013, Pages 203-210

  Downing, John W ^a   Baysinger, Curtis L ^a   Johnson, Raymond F ^a   Paschall, Ray L ^a  

^a VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

Druggable targets; Phosphodiesterase 5 inhibitors; Preeclampsia; Statins

Indexed keywords

4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; ACETYLSALICYLIC ACID; ANTIOXIDANT; ARGININE; CALCIUM; CARBON MONOXIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; HYDROGEN SULFIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE DONOR; PRAVASTATIN; SILDENAFIL; THIOREDOXIN 1; VITAMIN;

BRAZIL; DEVELOPING COUNTRY; DIET SUPPLEMENTATION; DRUG TARGETING; ENDEMIC DISEASE; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; PLACENTAL DELIVERY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; VASODILATATION;

EID: 84888642715     PISSN: 22107789     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preghy.2013.04.120     Document Type: Review

References (105)

1. A.B. Hill The environment and disease: association or causation? Proc R Soc Med 58 1965 295 300
2. K.S. Khan, D. Wojdyla, L. Say, A.M. Gülmezoglu, and P.F.A. Van Look WHO analysis of causes of maternal death: a systematic review Lancet 367 2006 1066 1074
3. A. Ahmed, and M.J. Cudmore Can the biology of VEGF and haem oxygenases help solve pre-eclampsia? Biochem Soc Trans 37 2009 1237 1242
4. B.M. Sibai, and J.R. Barton Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications Am J Obstet Gynecol 196 2007 514.e1 514.e9
5. El-S. Abdel-Hady, M. Fawzy, M. El-Negeri, M. Nezar, A. Ragab, and A.S. Helal Is expectant management of early-onset severe preeclampsia worthwhile in low-resource settings? Arch Gynecol Obstet 282 2010 23 27
6. T.R. Everett, I.B. Wilkinson, and C.C. Lees Drug development in preeclampsia: a 'no go' area? J Matern Fetal Neonatal Med 25 2012 50 52
7. S.H. Francis, J.L. Busch, and J.D. Corbin CGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action Pharmacol Rev 62 2010 525 563
8. J.W. Downing, R. Ramasubramanian, R.F. Johnson, B.H. Minzter, R.L. Paschall, and H.W. Sundell Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia Med Hypotheses 63 2004 1057 1064
9. A.J. Santos-Silva, E. Cairrão, M. Morgado, E. Álvarez, and I. Verde PDE4 and PDE5 regulate cyclic nucleotide relaxing effects in human umbilical arteries Eur J Pharmacol 582 2008 102 109
10. C.H. Maharaj, D. O'Toole, T. Lynch, J. Carney, J. Jarman, and B.D. Higgins Effects and mechanisms of action of sildenafil citrate in human chorionic arteries Reprod Biol Endocrinol 7 2009 34
11. O.M. Reslan, and R.A. Khalil Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia Cardiovasc Hematol Agents Med Chem 8 2010 204 226
12. B.J. Krause, M.A. Hanson, and P. Casanello Role of nitric oxide in placental vascular development and function Placenta 32 2011 797 805
13. L. Myatt Reactive oxygen and nitrogen species and functional adaptation of the placenta Placenta 31 Suppl. 2010 S66 S69
14. P. López-Jaramillo, W.D. Arenas, R.G. García, M.Y. Rincon, and M. López The role of the l-arginine-nitric oxide pathway in preeclampsia Ther Adv Cardiovasc Dis 2 2008 261 275
15. K. Matsubara, Y. Matsubara, S. Hyodo, T. Katayama, and M. Ito Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia J Obstet Gynaecol Res 36 2010 239 247
16. G. Boerrigter, and J.C. Burnett Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease Cardiovasc Drug Rev 25 2007 30 45
17. A. Ahmed New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications Thromb Res 127 Suppl. 3 2011 S72 S75
18. C. Grunewald, M. Kublickas, K. Carlstrom, N.-O. Lunell, and H. Nisell Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia Obstet Gynecol 86 1995 600 604
19. L. Belkacemi, S.A. Bainbridge, M.A. Dickinson, G.N. Smith, and C.H. Graham Glyceryl trinitrate inhibits hypoxia/reoxygenation-induced apoptosis in the syncytiotrophoblast of the human placenta Am J Pathol 170 2007 909 920
20. I.B. Barsoum, S.J. Renaud, and C.H. Graham Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues Am J Pathol 178 2011 2888 2896
21. S.V. Ramesar, I. Mackraj, P. Gathiram, and J. Moodley Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague-Dawley rats J Eur J Obstet Gynecol Reprod Biol 157 2011 136 140
22. C. Lees, H. Valensise, R. Black, K. Harrington, S. Byiers, and C. Romanini The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryltrintrate in the prophylaxis of preeclampsia and its complications: a randomized double-blind placebo-controlled trial Ultrasound Obstet Gynecol 12 1998 334 338
23. A. Trapani, L.F. Goncalves, S. De, and M.M. Pires Transdermal nitroglycerin in patients with severe pre-eclampsia with placental insufficiency: effect on uterine, umbilical and fetal middle cerebral artery resistance indices Ultrasound Obstet Gynecol 38 2011 389
24. M.A. Read, W.B. Giles, I.M. Leitch, A.L. Boura, and W.A. Walters Vascular responses to sodium nitroprusside in the human fetal-placental circulation Reprod Fertil Dev 7 1995 1557 1561
25. J.W. Downing, B.H. Minzter, R. Ramasubramanian, R.L. Paschall, J.J. York, and R.F. Johnson Phosphodiesterase (PDE5) receptor inhibition moderates the vasopressor effect of 5-hydroxytryptamine (5-HT) on the fetoplacental vasculature Anesthesiology 94 Suppl. 1 2001 A50
26. J.W. Downing, B.H. Minzter, R. Ramasubramanian, R.L. Paschall, J.J. York, and R.F. Johnson Phosphodiesterase (PDE5) placental receptor inhibition obtunds hypoxic fetoplacental vasoconstriction (HFPV) in the human placenta Anesthesiology 94 Suppl. 1 2001 A51
27. M. Wareing, J.E. Myers, M. O'Hara, L.C. Kenny, A.Y. Warren, and M.J. Taggart Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries Am J Obstet Gynecol 190 2004 1283 1290
28. E. Karasu, N. Kayacan, G. Sadan, and B. Dinc Endothelial dysfunction in the human umbilical artery due to preeclampsia can be prevented by sildenafil Clin Exp Hypertens 34 2012 79 85
29. G. Osol, and M. Mandala Maternal uterine vascular remodeling during pregnancy Physiology 24 2009 58 71
30. G. Osol, C. Barron, N. Gokina, and M. Mandala Inhibition of nitric oxide synthases abrogates pregnancy-induced uterine vascular expansive remodeling J Vasc Res 46 2009 478 486
31. J.G. Thornton, and J.L. Onwude Convulsions in pregnancy in related gorillas Am J Obstet Gynecol 167 1992 240 241
32. M. Aubuchon, L.C. Schulz, and D.J. Schust Preeclampsia: animal models for a human cure Proc Natl Acad Sci USA 108 2011 1197 1198
33. E. Podjarny, G. Losonczy, and C. Baylis Animal models of preeclampsia Semin Nephrol 24 2004 596 606
34. G.D. Helmbrecht, M.Y. Farhat, L. Lochbaum, H.E. Brown, K.T. Yadgarova, and G.S. Eglinton l-Arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat Am J Obstet Gynecol 175 1996 800 805
35. S. Kassab, M.T. Miller, R. Hester, J. Novak, and J.P. Granger Systemic hemodynamics and regional blood flow during chronic nitric oxide synthesis inhibition in pregnant rats Hypertension 31 1998 315 320
36. G. Osol, G. Celia, and N.I. Gokina Beneficial effects of Viagra (sildenafil) on fetal and vascular parameters in hypertensive pregnancy in the rat [abstract] 2005 International Congress of Physiological Sciences San Diego, CA [March 31-April 5]
37. S.V. Ramesar, I. Mackraj, P. Gathiram, and J. Moodley Sildenafil citrate improves fetal outcomes in pregnant, l-NAME treated, Sprague-Dawley rats Eur J Obstet Gynecol Reprod Biol 149 2010 22 26
38. A. Many, A. Fattal, Y. Leitner, M.J. Kupferminc, S. Harel, and A. Jaffa Neurodevelopmental and cognitive assessment of children born growth restricted to mothers with and without preeclampsia Hypertens Pregnancy 22 2003 25 29
39. A. Many, A. Fattal-Valevski, and Y. Leitner Neurodevelopmental and cognitive assessment of 6-year-old children born growth restricted Int J Gynaecol Obstet 89 2005 55 56
40. S.W. Cheng, H.C. Chou, K.I. Tsou, L.J. Fang, and P.N. Tsao Delivery before 32 weeks of gestation for maternal pre-eclampsia: neonatal outcome and 2-year developmental outcome Early Hum Dev 76 2004 39 46
41. O. Cauli, S. Herraiz, B. Pellicer, A. Pellicer, and V. Felipo Treatment with sildenafil prevents impairment of learning in rats born to pre-eclamptic mothers Neuroscience 171 2010 506 512
42. B. Pellicer, S. Herraiz, A. Leal, C. Simón, and A. Pellicer Prenatal brain damage in preeclamptic animal model induced by gestational nitric oxide synthase inhibition J Pregnancy 2011 [Article ID 809569, 6 pages]
43. J.M. Sasser, and C. Baylis Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy Am J Physiol Regul Integr Comp Physiol 298 2010 R433 R438
44. B. Pellicer, S. Herraiz, O. Cauli, R. Rodrigo, M. Asensi, and J. Cortijo Haemodynamic effects of long-term administration of sildenafil in normotensive pregnant and non-pregnant rats BJOG 118 2011 1471 1528
45. S. Herraiz, B. Pellicer, V. Serra, O. Cauli, J. Cortijo, and V. Felipo Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats BJOG 119 2012 1394 1402
46. J.S. Refuerzo, R.J. Sokol, J.V. Aranda, M. Hallak, J.W. Hotra, and M. Kruger Sildenafil citrate and fetal outcome in pregnant rats Fetal Diagn Ther 21 2006 259 263
47. P. Sánchez-Aparicio, D. Mota-Rojas, A.A. Nava-Ocampo, M.E. Trujillo-Ortega, A. Alfaro-Rodríguez, and E. Arch Effects of sildenafil on the fetal growth of guinea pigs and their ability to survive induced intrapartum asphyxia Am J Obstet Gynecol 198 2008 127.e1 127.e6
48. S.L. Miller, J.M. Loose, G. Jenkin, and E.M. Wallace The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus J Obstet Gynecol 102 2009 e1 e7
49. G. Jackson, N. Benjamin, N. Jackson, and M.J. Allen Effects of sildenafil citrate on human hemodynamics Am J Cardiol 83 1999 C13 C20
50. S.M. Shnider, T.K. Abboud, R. Artal, E.H. Henriksen, S.J. Stefani, and G. Levinson Maternal catecholamines decrease during labor after lumbar epidural anesthesia Am J Obstet Gynecol 147 1983 13 15
51. N.J. Sebire, and D. Talbert 'Cor placentale': placental intervillus/intravillus blood flow mismatch is the pathophysiological mechanism in severe intrauterine growth restriction due to uteroplacental disease Med Hypotheses 57 2001 354 357
52. M.C. Satterfield, F.W. Bazer, T.E. Spencer, and G. Wu Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction J Nutr 140 2010 251 258
53. A. Rolfo, A. Many, A. Racano, R. Tal, A. Tagliaferro, and F. Ietta Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies PLoS One 5 2010 e13288
54. R.A. Samangaya, G. Mires, A. Shennan, L. Skillern, D. Howe, and A. McLeod A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia Hypertens Pregnancy 28 2009 369 382
55. P. von Dadelszen, S. Dwinnell, L.A. Magee, B.C. Carleton, A. Gruslin, and B. Lee Sildenafil citrate therapy for severe early-onset intrauterine growth restriction BJOG 118 2011 624 628
56. J.W. Downing, C.L. Baysinger, R.F. Johnson, and R.L. Paschall Reversed umbilical artery end diastolic flow, sildenafil treatment and early still births BJOG 119 2012 509
57. L. Labartino, E. Mojdehi, and A.L. Mauro Management of hypotension following spinal anesthesia for cesarean section Anesth Analg 45 1966 179 182
58. F.C. Greiss, and D.L. Crandell Therapy for hypotension induced by spinal anesthesia during pregnancy: observations on gravid ewes JAMA 191 1965 793 796
59. W.D. Ngan Kee, K.S. Khaw, and F.F. Ng Prevention of hypotension during spinal anesthesia for cesarean delivery: an effective technique using combination phenylephrine infusion and crystalloid cohydration Anesthesiology 103 2005 744 750
60. S.R. Murphy, B. LaMarca, K. Cockrell, M. Arany, and J.P. Granger l-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats Am J Physiol Regul Integr Comp Physiol 302 2012 R259 R263
61. A. Lassala, F.W. Bazer, T.A. Cudd, S. Datta, D.H. Keisler, and M.C. Satterfield Parenteral administration of l-Arginine prevents fetal growth restriction in undernourished ewes J Nutr 140 2010 1242 1248
62. F. Facchinetti, G.R. Saade, I. Neri, C. Pizzi, M. Longo, and A. Volpe l-arginine supplementation in patients with gestational hypertension: a pilot study Hypertens Pregnancy 26 2007 121 130
63. F. Vadillo-Ortego, O. Perichart-Perera, S. Espino, M.A. Avila-Vergara, I. Ibarra, and R. Ahued Effect of supplementation during pregnancy with l-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomized controlled trial BMJ 342 2011 d2901
64. P. Sieroszewski, J. Suzin, and A. Karowicz-Bilińska Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (l-arginine) J Matern Fetal Neonatal Med 15 2004 363 366
65. C. Benedetto, L. Marozio, I. Neri, M. Giarola, A. Volpe, and F.L. Facchinetti Increased l-Citrulline/l-Arginine plasma ratio in severe preeclampsia Obstet Gynecol 96 2000 395 399
66. M. Noris, M. Todeschini, P. Cassis, F. Pasta, A. Cappellini, and S. Bonazzola L-Arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species Hypertension 43 2004 614 622
67. H. Alacam, Z.G. Dikmen, H. Yaman, E. Cakir, O. Deren, and E.O. Akgul The role of asymmetric dimethyl arginine and oxidant/antioxidant system in preeclampsia Fetal Pediatr Pathol 30 2011 387 393
68. Y.J. Kim, H.S. Park, H.Y. Lee, E.H. Ha, S.H. Suh, and S.K. Oh Reduced l-arginine level and decreased placental eNOS activity in preeclampsia Placenta 27 2006 438 444
69. R.H. Böger, A. Diemert, E. Schwedhelm, N. Lüneburg, R. Maas, and K. Hecher The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia Gynecol Obstet Invest 69 2010 1 13
70. J.M. Roberts, L.M. Bodnar, T.E. Patrick, and R.W. Powers The role of obesity in preeclampsia Pregnancy Hypertens 1 2011 6 16
71. M. Anderssohn, L.M. Maass, A. Diemert, N. Lüneburg, D. Atzler, and K. Hecher Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia Eur J Obstet Gynecol Reprod Biol 161 2012 152 156
72. D. Chen, H. Wang, H. Huang, and M. Dong Vascular endothelial growth factor attenuates Nomega-nitro-l-arginine methyl ester-induced preeclampsia-like manifestations in rats Clin Exp Hypertens 30 2008 606 615
73. J. Mateus, E. Bytautiene, F. Lu, E.H. Tamayo, A. Betancourt, and G.D. Hankins Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1 Am J Physiol Heart Circ Physiol 301 2011 H1781 H1787
74. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
75. R.J. Levine, C. Lam, C. Qian, K.F. Yu, S.E. Maynard, and B.P. Sachs Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005
76. M.O. Bahtiyar, C. Buhimschi, V. Ravishanka, J. Copel, E. Norwitz, and S. Julien Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction Am J Obstet Gyncol 196 2007 72 76
77. A. Makris, C. Thornton, J. Thompson, S. Thomson, R. Martin, and R. Ogle Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1 Kidney Int 71 2007 977 984
78. A. Jeyabalan, S. McGonigal, C. Gilmour, C.A. Hubel, and A. Rajakumar Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia Placenta 29 2008 555 563
79. R. Thadhani, T. Kisner, H. Hagmann, V. Bossung, S. Noack, and W. Schaarschimdt Pilot study of extracorporeal removal of soluble Fms-like tyrosine kinase 1 in preeclampsia Circulation 124 2011 940 950
80. A. Ladaique, A. Le Roch, L. Storme, and P. Deruelle Maternal and fetal effects of bay 41-2272, a direct soluble guanylate cyclase activator, in a model of preeclampsia and intra uterine growth restriction Am J Obstet Gynecol 201 2009 S12
81. T. Tsuruda, K. Hatakeyama, H. Masuyama, Y. Sekita, T. Imamura, and Y. Asada Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1α in rat heart Am J Physiol Heart Circ Physiol 297 2009 H1274 H1280
82. K.G. Pringle, K.L. Kind, A.N. Sferruzzi-Perri, J.G. Thompson, and C.T. Roberts Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy Hum Reprod Update 16 2010 415 431
83. R. Tal, A. Shaish, I. Barshack, S. Polak-Charcon, A. Afek, and A. Volkov Effects of hypoxia-inducible factor-1α overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction Am J Pathol 177 2010 2950 2962
84. M. Cudmore, S. Ahmad, A.A. Bahjat, F. Takeshi, H. Coxall, and K. Chudasama Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1 Circulation 115 2007 1789 1797
85. E.M. George, M. Arany, K. Cockrell, M.V. Storm, D.E. Stec, and J.P. Granger Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats Am J Physiol Regul Integr Comp Physiol 301 2011 R1495 R1500
86. E.M. George, K. Cockrell, M. Aranay, E. Csongradi, D.E. Stec, and J.P. Granger Induction of heme oxygenase 1 attenuates placental ischemia induced hypertension Hypertension 57 2011 941 948
87. E.M. George, D. Colson, J. Dixon, A.C. Palei, and J.P. Granger Heme oxygenase-1 attenuates hypoxia-induced sFlt-1 and oxidative stress in placental villi through its metabolic products CO and bilirubin Int J Hypertens 2012 2012 486053
88. L.E. Keyes, J.F. Armaza, S. Niermeyer, E. Vargas, D.A. Young, and L.G. Moore Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in bolivia Pediatr Res 54 2003 20 25
89. S.A. Karumanchi, and R.J. Levine How does smoking reduce the risk of preeclampsia? Hypertension 55 2010 1100 1101
90. E.M. George, A.C. Palei, and J.P. Granger Endothelin as a final common pathway in the pathophysiology of preeclampsia: therapeutic implications Curr Opin Nephrol Hypertens 21 2012 157 162
91. P.K. Aggarwal, N. Chandel, V. Jain, and V. Jha The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia J Hum Hypertens 26 2012 236 241
92. M.M. Costantine, and K. Cleary Pravastatin for the prevention of preeclampsia in high-risk pregnant women Obstet Gynecol 121 2013 349 353
93. E. Lecarpentier, O. Morel, T. Fournier, E. Elefant, P. Chavatte-Palmer, and V. Tsatsaris Statins and pregnancy: between supposed risks and theoretical benefits Drugs 72 2012 773 788
94. R. Vidavalur, S.V. Penumathsa, L. Zhan, M. Thirunavukkarasu, and N. Maulik Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor Vasc Pharmacol 45 2006 91 95
95. X.M. Liu, K.J. Peyton, X. Wang, and W. Durante Sildenafil stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells via distinct signaling pathways Biochem Pharmacol 84 2012 1045 1054
96. Y.H. Liu, C.D. Yan, and J.S. Bian Hydrogen sulphide: a novel signaling molecule in the vascular system J Cardiovasc Pharmacol 58 2011 560 569 [Review]
97. K.M. Holwerda, E.M. Bos, A. Rajakumar, C. Ris-Stalpers, M.G. Van Pampus, and A. Timmer Hydrogen sulphide producing enzymes in pregnancy and preeclampsia Placenta 33 2012 518 521
98. P. Patel, M. Vatish, J. Heptinstall, R. Wang, and R.J. Carson The endogenous production of hydrogen sulphide in intrauterine tissues Reprod Biol Endocrinol 7 2009 10
99. J.W. Downing, C.L. Baysinger, R.F. Johnson, and R. Paschall Sildenafil for the treatment of preeclampsia Hypertens Pregnancy 29 2010 251 252
100. R.L. Goldenberg, E.M. McClure, E.R. Macguire, B.D. Kamath, and A.H. Jobe Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries Int J Gynaecol Obstet 113 2011 91 95
101. F. Audibert, I. Boucoiran, N. Aleksandrov, N. Aleksandrov, E. Delvin, and E. Bujold Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women Am J Obstet Gynecol 203 2010 383.e1 383.e8
102. S. Sunderji, E. Gaziano, D. Wothe, L.C. Rogers, B. Sibai, and A. Karumanchi Automated assays for sVEGF R1 and PIGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study Am J Obstet Gynecol 202 2010 40.e1 40.e7
103. A.A. Baschat Venous Doppler evaluation of the growth-restricted fetus Clin Perinatol 38 2011 103 112
104. I. Buhimschi, E. Funai, G. Zhao, A. Dulay, S. Lee, and C. Han Assessment of global protein misfolding load by urine "Congo Red Dot" test for diagnosis and prediction of outcome in women with preeclampsia (PE) Am J Obstet Gynecol 201 2009 12 13
105. Davy H: Collected Works. London. Smith, Elder 1840; 8: 318.